Bloodless lung transplantation in Jehovah's Witnesses: Impact on perioperative parameters and outcome compared with a matched control group

Transplantation Proceedings

Volumn 45, Issue 1, 2013, Pages 335-341

  Partovi, S ^a   Bruckner, B A ^a   Staub, D ^b   Ortiz, G ^a   Scheinin, S A ^a   Seethamraju, H ^a   Loebe, M ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN;

AGED; ARTERIAL GAS; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CASE REPORT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE; JEHOVAH'S WITNESS; LENGTH OF STAY; LUNG ARTERY PRESSURE; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MALE; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; SURVIVAL; TREATMENT OUTCOME;

AGED; ATTITUDE TO HEALTH; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INTENSIVE CARE; JEHOVAH'S WITNESSES; LENGTH OF STAY; LUNG TRANSPLANTATION; MALE; OXYGEN; PATIENT ACCEPTANCE OF HEALTH CARE; PERIOPERATIVE PERIOD; TIME FACTORS; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84873300140     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.06.057     Document Type: Article

References (52)

1. L.M. Sarteschi Jehovah's witnesses, blood transfusions and transplantations Transplant Proc 36 2004 499
2. J. Majeski Advances in general and vascular surgical care of Jehovah's Witnesses Int Surg 85 2000 257
3. D.A. Ott, D.A. Cooley Cardiovascular surgery in Jehovah's Witnesses Report of 542 operations without blood transfusion JAMA 238 1977 1256
4. N. Jabbour, S. Gagandeep, H. Shah Impact of a transfusion-free program on non-Jehovah's Witness patients undergoing liver transplantation Arch Surg 141 2006 913
5. T. Wobbes, B.L. Bemelmans, J.H. Kuypers Risk of postoperative septic complications after abdominal surgical treatment in relation to perioperative blood transfusion Surg Gynecol Obstet 171 1990 59
6. S.L. Stramer, F.B. Hollinger, L.M. Katz Emerging infectious disease agents and their potential threat to transfusion safety Transfusion 49 Suppl 2 2009 1S
7. E.C. Vamvakas, M.A. Blajchman Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention Blood 113 2009 3406
8. G.B. Schreiber, M.P. Busch, S.H. Kleinman The risk of transfusion-transmitted viral infections The Retrovirus Epidemiology Donor Study N Engl J Med 334 1996 1685
9. E.M. Sloand, E. Pitt, H.G. Klein Safety of the blood supply JAMA 274 1995 1368
10. A.F. Corno, H. Laks, L.W. Stevenson Heart transplantation in a Jehovah's Witness J Heart Transplant 5 1986 175
11. C.M. Burnett, J.M. Duncan, J.D. Vega Heart transplantation in Jehovah's Witnesses An initial experience and follow-up Arch Surg 125 1990 1430
12. P. Seu, G. Neelankanta, M. Csete Liver transplantation for fulminant hepatic failure in a Jehovah's Witness Clin Transplant 10 1996 404
13. O. Detry, A. Deroover, J. Delwaide Avoiding blood products during liver transplantation Transplant Proc 37 2005 2869
14. H.C. Ramos, S. Todo, Y. Kang Liver transplantation without the use of blood products Arch Surg 129 1994 528
15. N.J. Snook, H.A. O'Beirne, S. Enright Use of recombinant human erythropoietin to facilitate liver transplantation in a Jehovah's Witness Br J Anaesth 76 1996 740
16. D.B. Kaufman, D.E. Sutherland, D.S. Fryd A single-center experience of renal transplantation in thirteen Jehovah's Witnesses Transplantation 45 1988 1045
17. U. Boggi, F. Vistoli, M. Del Chiaro Kidney and pancreas transplants in Jehovah's witnesses: ethical and practical implications Transplant Proc 36 2004 601
18. U. Boggi, M. Del Chiaro, F. Vistoli Pancreas transplantation from marginal donors Transplant Proc 36 2004 566
19. J.V. Conte, J.B. Orens Lung transplantation in a Jehovah's Witness J Heart Lung Transplant 18 1999 796
20. A.M. Grande, M. Rinaldi, A.M. D'Armini Lung transplantation in a Jehovah's witness Case report in a twinning procedure J Cardiovasc Surg (Torino) 44 2003 131
21. Z.M. Bodnaruk, C.J. Wong, M.J. Thomas Meeting the clinical challenge of care for Jehovah's Witnesses Transfus Med Rev 18 2004 105
22. J.L. Carson, H. Noveck, J.A. Berlin Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion Transfusion 42 2002 812
23. H.L. Corwin Anemia and blood transfusion in the critically ill patient: role of erythropoietin Crit Care 8 suppl 2 2004 S42
24. I. Kleinman Written advance directives refusing blood transfusion: ethical and legal considerations Am J Med 96 1994 563
25. J. Adamson Erythropoietin, iron metabolism, and red blood cell production Semin Hematol 33 1996 5
26. M.A. Goldberg Erythropoiesis, erythropoietin, and iron metabolism in elective surgery: preoperative strategies for avoiding allogeneic blood exposure Am J Surg 170 1995 37S
27. O. Detry, A. Deroover, J. Delwaide Avoiding blood products during liver transplantation Transplant Proc 37 2005 2869
28. A. Ashworth, A.A. Klein Cell salvage as part of a blood conservation strategy in anaesthesia Br J Anaesth 105 2010 401
29. K.R. Williamson, H.F. Taswell Intraoperative blood salvage: a review Transfusion 31 1991 662
30. D.A. Spain, F.B. Miller, T.M. Bergamini Quality assessment of intraoperative blood salvage and autotransfusion Am Surg 63 1997 1059
31. D.E. Lammermeier, J.M. Duncan, R.C. Kuykendall Cardiac transplantation in a Jehovah's witness Tex Heart Inst J 15 1988 189
32. N. Marczin, D. Royston, M. Yacoub Pro: lung transplantation should be routinely performed with cardiopulmonary bypass J Cardiothorac Vasc Anesth 14 2000 739
33. K. McRae Con: lung transplantation should not be routinely performed with cardiopulmonary bypass J Cardiothorac Vasc Anesth 14 2000 746
34. C.C. Hlozek, N.G. Smedira, T.J. Kirby Cardiopulmonary bypass (CPB) for lung transplantation Perfusion 12 1997 107
35. A.N. Triantafillou, M.K. Pasque, C.B. Huddleston Predictors, frequency, and indications for cardiopulmonary bypass during lung transplantation in adults Ann Thorac Surg 57 1994 1248
36. C.C. Hlozek, N.G. Smedira, T.J. Kirby Cardiopulmonary bypass (CPB) for lung transplantation Perfusion 12 1997 107
37. A. de Hoyos, W. Demajo, G. Snell Preoperative prediction for the use of cardiopulmonary bypass in lung transplantation J Thorac Cardiovasc Surg 106 1993 787
38. J.S. Gammie, J. Cheul Lee, S.M. Pham Cardiopulmonary bypass is associated with early allograft dysfunction but not death after double-lung transplantation J Thorac Cardiovasc Surg 115 1998 990
39. J.V. Conte, J.B. Orens Lung transplantation in a Jehovah's Witness J Heart Lung Transplant 18 1999 796
40. U. Boggi, F. Vistoli, M. Del Chiaro Kidney and pancreas transplants in Jehovah's witnesses: ethical and practical implications Transplant Proc 36 2004 601
41. C.M. Cserti-Gazdewich, T.K. Waddell, L.G. Singer Passenger lymphocyte syndrome with or without immune hemolytic anemia in all Rh-positive recipients of lungs from rhesus alloimmunized donors: three new cases and a review of the literature Transfus Med Rev 23 2009 134
42. P.M. Naik, G.M. Lyon 3rd, A. Ramirez Dapsone-induced hemolytic anemia in lung allograft recipients J Heart Lung Transplant 27 2008 1198
43. J.L. Carson, H. Noveck, J.A. Berlin Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion Transfusion 42 2002 812
44. H.L. Corwin, A. Gettinger, R.G. Pearl Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial JAMA 288 2002 2827
45. H.G. Klein The prospects for red-cell substitutes N Engl J Med 342 2000 1666
46. P.A. Remmers, A.J. Speer Clinical strategies in the medical care of Jehovah's Witnesses Am J Med 119 2006 1013
47. Y.P. Agrawal, M. Freedman, Z.M. Szczepiorkowski Long-term transfusion of polymerized bovine hemoglobin in a Jehovah's Witness following chemotherapy for myeloid leukemia: a case report Transfusion 45 2005 1735
48. C. Cothren, E.E. Moore, P.J. Offner Blood substitute and erythropoietin therapy in a severely injured Jehovah's witness N Engl J Med 346 2002 1097
49. J. Walsham, J.F. Fraser, D. Mullany The use of recombinant activated factor VII for refractory bleeding post complex cardiothoracic surgery Anaesth Intensive Care 34 2006 13
50. E.E. Moore, J.M. Burch, R.J. Franciose Staged physiologic restoration and damage control surgery World J Surg 22 1998 1184
51. R.S. Miller, J.A. Morris Jr., J.J. Diaz Jr. Complications after 344 damage-control open celiotomies J Trauma 59 2005 1365
52. M.R. Grotz, N.W. Gummerson, A. Gansslen Staged management and outcome of combined pelvic and liver trauma An international experience of the deadly duo Injury 37 2006 642